Tela Competitors

Stocks . USA . 
Stock . Tela Bio
TELA Stock  USD 3.14  0.11  3.63%   
Tela Bio competes with Sight Sciences, Tactile Systems, Clearpoint Neuro, CVRx, and Neuropace; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Tela Bio competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Tela Bio to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Tela Bio Correlation with its peers.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Tela Bio competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.163.146.55
Details
Intrinsic
Valuation
LowRealHigh
0.122.475.88
Details
Naive
Forecast
LowNextHigh
0.063.116.52
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.782.973.16
Details

Tela Bio Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tela Bio and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Tela and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tela Bio does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TMDX
+ 0.93
SGHT
NPCE
+ 0.83
TCMD
RXST
+ 0.77
SGHT
CVRX
+ 0.73
TCMD
DCTH
+ 0.64
CLPT
NPCE
+ 0.64
CVRX
  
High negative correlations   
TMDX
- 0.91
CVRX
CVRX
- 0.87
SGHT
TCMD
- 0.75
SGHT
NPCE
- 0.67
SGHT
TMDX
- 0.66
TCMD
RXST
- 0.65
TCMD

Risk-Adjusted Indicators

There is a big difference between Tela Stock performing well and Tela Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tela Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SGHT  2.97 (0.55) 0.00  0.88  0.00 
 0.00 
 6.65 
(7.84)
 18.22 
TBIO  18.73  3.42  0.16 (10.93) 17.65 
(28.28)
 71.98 
(24.09)
 139.53 
TCMD  2.17  0.46  0.17  0.49  2.45 
(2.52)
 5.99 
(3.29)
 15.80 
CLPT  2.63 (0.01)(0.03) 0.09  3.52 
(2.84)
 6.76 
(3.91)
 24.80 
CVRX  3.84  0.92  0.20  2.05  3.30 
(4.66)
 10.68 
(6.75)
 41.08 
NPCE  3.41  0.74  0.16 (1.56) 2.84 
(4.14)
 9.73 
(5.36)
 35.38 
TMDX  3.15 (0.83) 0.00 (4.11) 0.00 
 0.00 
 5.99 
(7.43)
 39.98 
DCTH  2.60  0.20  0.03  1.04  3.14 
(2.84)
 6.50 
(3.88)
 20.21 
RXST  1.58 (0.09) 0.00  0.26  0.00 
 0.00 
 2.19 
(4.61)
 12.89 
AXGN  2.27  0.30  0.00 (0.11) 3.71 
(2.28)
 4.73 
(5.50)
 21.60 
All Fundamental Data

Tela Bio Competitive Analysis

The better you understand Tela Bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tela Bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tela Bio's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
TELA SGHT TBIO TCMD CLPT CVRX NPCE TMDX DCTH RXST
 3.63 
 3.14 
Tela
 2.05 
 3.99 
Sight
 0.67 
 2.98 
Telesis
 3.22 
 19.54 
Tactile
 2.15 
 12.37 
Clearpoint
 0.07 
 15.32 
CVRx
 3.41 
 10.60 
Neuropace
 0.46 
 86.71 
TransMedics
 5.88 
 11.88 
Delcath
 1.03 
 46.88 
Rxsight
Market Volatility
(90 Days Market Risk)
Risky
Unstable
Out of control
Not too volatile
Somewhat reliable
Slightly risky
Moderately volatile
Very steady
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Modest
Very Weak
OK
Good
Very Weak
Good
OK
Very Weak
Modest
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Above Average
Dangerous
Low
Low
About Average
Quite High
Below Average
Below Average
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Not Rated
Strong Buy
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
3.83
16.73
5.93
2.31
10.33
16.82
9.86
12.11
1.57
11.54
Net Asset
78.05 M
166.65 M
70.41 M
281.44 M
42.66 M
115.23 M
107.65 M
706.05 M
38.61 M
182.55 M
Profit Margin
-0.6
-0.63
-2.53
0.0542
-0.6
-1.24
-0.37
0.0814
N/A
-0.24
EBITDA
(40.63 M)
(49.41 M)
(31.05 M)
24.54 M
(20.99 M)
(43.1 M)
(22.83 M)
(7.6 M)
(46.11 M)
(41.04 M)
Operating Margin
-0.49
-0.56
-6.76
0.0928
-0.64
-0.97
-0.2
0.0361
-0.5
-0.26
Current Valuation
147.91 M
117.81 M
61.1 M
419.37 M
323.34 M
322 M
333.06 M
3.1 B
368.93 M
1.66 B
Price To Book
22.99
2.12
1.11
2.26
11.77
5.7
32.21
13.86
44.32
6.81
Retained Earnings
(320.89 M)
(294.79 M)
(161.47 M)
18.89 M
(172.46 M)
(477.38 M)
(503.81 M)
(503.7 M)
(505.16 M)
(594.64 M)
Current Asset
N/A
N/A
3.28 M
64.23 M
8.1 M
N/A
N/A
N/A
14.6 M
N/A
Beta
0.97
2.73
1.76
1.17
1.11
1.11
1.8
2.07
0.76
1.19
Number Of Employees
227
214
101
992
107
200
184
584
76
374
Shares Outstanding
39.39 M
50.4 M
1.77 M
24 M
27.58 M
24.26 M
29.85 M
33.56 M
31.97 M
40.3 M
Cash Flow From Operations
(40.86 M)
(47.18 M)
(34.67 M)
35.85 M
(13.72 M)
(39.02 M)
(19.7 M)
(13.03 M)
(31.25 M)
(41.59 M)
Total Debt
41.08 M
35.41 M
34.38 M
50.38 M
13.94 M
30.61 M
72.39 M
515.95 M
10.19 M
3.01 M
Return On Equity
-3.42
-0.45
-1.48
0.0791
-0.68
-0.79
-2.15
0.19
-4.79
-0.14
Return On Asset
-0.41
-0.19
-0.27
0.0462
-0.28
-0.31
-0.15
0.0284
-0.82
-0.0992
Number Of Shares Shorted
335.91 K
977.46 K
29.7 K
978.4 K
759.9 K
2.06 M
290.4 K
8.98 M
1.18 M
3.03 M
Book Value Per Share
-0.25
1.88
-11.59
8.66
1.05
2.69
0.33
6.26
0.69
6.89
Current Liabilities
N/A
N/A
16.98 M
13.79 M
1.85 M
N/A
N/A
N/A
6.31 M
N/A
Total Asset
78.05 M
166.65 M
70.41 M
281.44 M
42.66 M
115.23 M
107.65 M
706.05 M
38.61 M
182.55 M
Debt To Equity
3.33
0.18
0.16
0.66
0.28
0.003
1.08
0.36
3.13
0.41
Short Ratio
0.91
4.06
0.42
4.08
2.77
4.46
2.7
4.25
5.26
5.07
Target Price
9.2
5.66
4.0
24.0
16.33
16.5
15.33
123.88
21.33
63.0
Shares Owned By Institutions
51.72
51.0
32.97
98.05
30.53
71.9
82.89
96.83
38.12
89.52
Market Capitalization
123.68 M
201.09 M
5.73 M
468.9 M
341.22 M
371.72 M
316.39 M
2.92 B
379.85 M
1.89 B
Price To Earning
N/A
N/A
71.32
23.07
-3.36
0.19
N/A
N/A
-0.12
42.55
Price To Earnings To Growth
N/A
N/A
N/A
17.24
-0.46
N/A
N/A
N/A
-0.05
0.03
Price To Sales
1.8
2.53
0.29
1.65
11.21
7.87
4.14
7.29
31.98
14.73
Net Income
(46.66 M)
(55.55 M)
(47.72 M)
28.52 M
(22.09 M)
(41.2 M)
(32.96 M)
(25.03 M)
(47.68 M)
(48.61 M)
Earnings Per Share
-1.69
-1.01
-30.42
0.65
-0.69
-2.69
-0.98
0.93
-1.17
-0.81
Shares Owned By Insiders
7.32
20.4
37.9
1.95
7.83
4.39
4.1
3.17
2.7
5.0
Revenue
58.45 M
81.06 M
27.51 M
274.42 M
23.95 M
39.3 M
65.42 M
241.62 M
2.06 M
89.08 M
Working Capital
54.76 M
150.62 M
22.17 M
104.24 M
28.74 M
104.23 M
76.49 M
455.72 M
20.71 M
147.5 M
Cash And Equivalents
27.73 M
220.1 M
654.75 M
23.35 M
45.14 M
109.98 M
92.41 M
204.46 M
10.2 M
128.62 M
Cash Per Share
1.9
4.6
8.7
1.16
1.84
5.34
3.72
6.41
1.19
4.65
Gross Profit
27.85 M
58.97 M
15.6 M
175.98 M
13.53 M
17.47 M
32.49 M
65.27 M
2.03 M
21.33 M
Day Typical Price
3.12
4.0
2.98
19.4
12.34
15.15
10.58
87.53
11.69
46.9
Accumulation Distribution
0.0502
0.0368
0.1
0.042
0.0475
0.0454
0.028
0.0321
0.0634
0.0409
Market Facilitation Index
0.16
0.15
0.33
0.83
0.6
0.7
0.3
2.87
0.76
1.96
Daily Balance Of Power
0.6875
0.5333
(0.06)
0.7349
0.4333
0.0143
1.166667
(0.14)
0.8684
0.2449
Period Momentum Indicator
0.11
0.08
(0.02)
0.61
0.26
0.01
0.35
(0.40)
0.66
0.48
Rate Of Daily Change
1.04
1.02
0.99
1.03
1.02
1.0
1.03
1.0
1.06
1.01
Day Median Price
3.11
4.01
2.99
19.34
12.33
15.06
10.57
87.95
11.6
46.91
Price Action Indicator
0.085
0.025
(0.01)
0.51
0.17
0.26
0.2
(1.44)
0.61
0.21
Relative Strength Index
58.46
37.99
48.84
70.52
52.83
65.87
67.44
40.38
62.93
44.88
Coefficient Of Variation
1320.36
(565.08)
949.7
505.4
10438.86
735.91
867.7
(648.00)
1428.06
(1,266)
Mean Deviation
2.69
3.0
18.73
2.17
2.63
3.84
3.44
3.15
2.6
1.58
Jensen Alpha
0.2983
(1.14)
3.42
0.457
(0.01)
0.7482
0.3049
(0.83)
0.2048
(0.09)
Total Risk Alpha
(0.32)
(1.38)
(1.99)
0.0883
(0.59)
(0.20)
(0.28)
(1.67)
(0.35)
(0.55)
Sortino Ratio
0.0426
N/A
0.164
0.1652
(0.03)
0.1597
0.1343
N/A
0.0316
N/A
Downside Variance
8.01
N/A
393.17
8.83
13.26
18.71
12.49
N/A
11.19
N/A
Standard Deviation
3.41
4.0
32.2
3.18
3.66
6.1
5.31
5.17
3.48
2.19
Kurtosis
0.4355
0.4017
6.69
4.46
3.01
8.93
10.24
15.33
1.26
1.78
Potential Upside
6.43
6.65
71.98
5.99
6.76
10.68
9.73
5.99
6.5
2.19
Treynor Ratio
(0.63)
(0.22)
(10.93)
0.4881
0.0861
1.49
0.2585
(4.11)
1.04
0.2598
Maximum Drawdown
15.4
18.22
139.53
15.8
24.8
41.08
35.38
39.98
20.21
12.89
Variance
11.62
15.97
1036.71
10.1
13.4
37.17
28.22
26.74
12.08
4.81
Market Risk Adjusted Performance
(0.62)
(0.21)
(10.92)
0.4981
0.0961
1.5
0.2685
(4.10)
1.05
0.2698
Risk Adjusted Performance
0.0657
(0.13)
0.0903
0.1588
0.0152
0.1126
0.0967
(0.11)
0.0613
(0.05)
Skewness
0.5843
(0.06)
2.11
0.274
(0.1)
2.13
2.39
(2.72)
0.2072
(0.66)
Semi Deviation
2.62
N/A
17.65
2.45
3.52
3.48
3.01
N/A
3.14
N/A
Information Ratio
0.0354
(0.21)
0.101
0.1546
(0.03)
0.1133
0.0893
(0.18)
0.0304
(0.14)
Value At Risk
(4.58)
(7.84)
(24.09)
(3.29)
(3.91)
(8.22)
(6.19)
(7.43)
(3.88)
(4.61)
Expected Short fall
(3.57)
N/A
(28.28)
(2.52)
(2.84)
(4.66)
(4.11)
N/A
(2.84)
N/A
Downside Deviation
2.83
N/A
19.83
2.97
3.64
4.32
3.53
N/A
3.34
N/A
Semi Variance
6.88
N/A
311.37
6.01
12.42
12.11
9.08
N/A
9.85
N/A

Tela Bio Competition Performance Charts

Five steps to successful analysis of Tela Bio Competition

Tela Bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tela Bio in relation to its competition. Tela Bio's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Tela Bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tela Bio's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tela Bio, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Tela Bio position

In addition to having Tela Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:
How To Invest In Tela
Details
Is Tela Stock a good investment?
Details
What is Tela Bio's Net Worth?
Details
Largest Medical Equipment Companies
View
Largest Medical Devices Companies
View
Check out Tela Bio Correlation with its peers.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY